Literature DB >> 12191812

Mecamylamine blocks enhancement of reference memory but not working memory produced by post-training injection of nicotine in rats tested on the radial arm maze.

Russell W Brown1, Karen S Beale, G D Jay Frye.   

Abstract

The focus of this study was to analyze whether the psychostimulant nicotine would enhance reference and working memory consolidation in rats tested on the 8-arm radial arm maze. Mecamylamine, a nicotine antagonist, was used to attempt to block the enhancement of memory consolidation. All rats were given one training trial/day for 12 consecutive days, and 4 arms were baited. Rats were separated into five groups: the saline-nicotine group received an intraperitoneal (i.p.) injection of saline immediately after each trial followed 15 min later by an subcutaneous (s.c.) injection of nicotine (0.6 mg/kg free base); the nicotine-delay group received an s.c. injection of nicotine 2 h after each training trial, two groups received an i. p. injection of one of two different doses of mecamylamine (2.5 and 6.0 mg/kg) immediately after each trial, which was followed 15 min later by an s.c. nicotine injection, and a control group received an i.p. injection of saline immediately and 15 min after each training trial. Results showed that the saline-nicotine group made fewer reference and working memory errors than the saline- or nicotine-delay groups, but only the effect of nicotine on reference memory was blocked by the higher dose of mecamylamine. It appears from these results that nicotine's effects on reference and working memory may be mediated through different mechanisms. Copyright 2002 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12191812     DOI: 10.1016/s0166-4328(02)00047-5

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  7 in total

1.  Differential effects of M1 muscarinic receptor blockade and nicotinic receptor blockade in the dorsomedial striatum on response reversal learning.

Authors:  Arianna Tzavos; Jane Jih; Michael E Ragozzino
Journal:  Behav Brain Res       Date:  2004-09-23       Impact factor: 3.332

2.  3,4-dihydroxyphenylethanol attenuates spatio-cognitive deficits in an Alzheimer's disease mouse model: modulation of the molecular signals in neuronal survival-apoptotic programs.

Authors:  Mohanasundaram Arunsundar; Thukani Sathanantham Shanmugarajan; Velayutham Ravichandran
Journal:  Neurotox Res       Date:  2014-10-02       Impact factor: 3.911

Review 3.  Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: an overview of preclinical and clinical findings.

Authors:  Susanne Graef; Peter Schönknecht; Osama Sabri; Ulrich Hegerl
Journal:  Psychopharmacology (Berl)       Date:  2011-01-08       Impact factor: 4.530

4.  Chronic cerebral ischaemia forms new cholinergic mechanisms of learning and memory.

Authors:  E I Zakharova; Z I Storozheva; A M Dudchenko; A A Kubatiev
Journal:  Int J Alzheimers Dis       Date:  2010-12-20

5.  Intrahippocampal blockade of nicotinic or muscarinic receptors fails to impair nonnavigational spatial memory in macaques.

Authors:  Elyssa M LaFlamme; Ludise Malkova; Patrick A Forcelli
Journal:  Behav Neurosci       Date:  2021-02-25       Impact factor: 2.154

6.  Long-term effects of maternal deprivation on cholinergic system in rat brain.

Authors:  Branka Marković; Nevena V Radonjić; Milan Aksić; Branislav Filipović; Nataša Petronijević
Journal:  Biomed Res Int       Date:  2014-03-10       Impact factor: 3.411

7.  Effect of C-phycocyanin on HDAC3 and miRNA-335 in Alzheimer's disease.

Authors:  Zhengyu Li; Li Gan; Si Yan; Yufang Yan; Wei Huang
Journal:  Transl Neurosci       Date:  2020-05-29       Impact factor: 1.757

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.